EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw unusually-high trading volume on Friday . 286,351 shares changed hands during trading, an increase of 133% from the previous session’s volume of 123,027 shares.The stock last traded at $95.03 and had previously closed at $94.60.
Analysts Set New Price Targets
A number of research firms have weighed in on ESLOY. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft initiated coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They issued a “hold” rating on the stock. Finally, Zacks Research downgraded EssilorLuxottica from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, EssilorLuxottica has an average rating of “Moderate Buy”.
Read Our Latest Stock Report on EssilorLuxottica
EssilorLuxottica Stock Performance
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Further Reading
- Five stocks we like better than EssilorLuxottica
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
